|
MechanismmAChRs antagonists |
|
|
|
|
Drug Highest PhaseApproved |
First Approval Ctry. / Loc.Japan |
First Approval Date20 Jul 1968 |
Target- |
Mechanism- |
|
|
|
Inactive Indication- |
Drug Highest PhasePreclinical |
First Approval Ctry. / Loc.- |
First Approval Date- |
Target- |
Mechanism- |
|
|
|
Inactive Indication- |
Drug Highest PhasePreclinical |
First Approval Ctry. / Loc.- |
First Approval Date- |
100 Clinical Results associated with Zhejiang Ruitong Biotechnology Co., Ltd.
0 Patents (Medical) associated with Zhejiang Ruitong Biotechnology Co., Ltd.
100 Deals associated with Zhejiang Ruitong Biotechnology Co., Ltd.
100 Translational Medicine associated with Zhejiang Ruitong Biotechnology Co., Ltd.